PAHC vs ZTS
PAHC: Phibro manufactures and distributes nutritional additives, pharmaceutical products, and specialty ingredients for animal health and nutritional enhancement worldwide. ZTS: Zoetis is the world's leading animal health company, providing a comprehensive portfolio of medicines, vaccines, and diagnostic technologies for both pets and livestock.
Side-by-side fundamentals
| Metric | PAHC | ZTS | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $33.81 | $74.19 | |
| Market cap as of 2026-07-23 | $1.4B | $31.7B | |
| P/E as of 2026-07-23 | 14.42 | 12.01 | ZTS lower |
| PEG as of 2026-07-23 | 0.62 | 1.69 | PAHC lower |
| Net margin as of 2026-07-23 | +6.3% | +27.8% | ZTS higher |
| Gross margin as of 2026-07-23 | +32.8% | +71.8% | ZTS higher |
| Operating margin as of 2026-07-23 | +12.0% | +34.8% | ZTS higher |
| ROE as of 2026-07-23 | +29.5% | +62.4% | ZTS higher |
| ROA as of 2026-07-23 | +6.8% | +17.5% | ZTS higher |
| Debt / equity as of 2026-07-23 | 2.03 | 2.80 | PAHC lower |
| Revenue growth (YoY) as of 2026-07-23 | +26.0% | +2.4% | PAHC higher |
| Revenue CAGR (3y) SEC XBRL | +11.2% | +5.4% | PAHC higher |
| Dividend yield as of 2026-07-23 | +1.4% | +1.6% | ZTS higher |
| Dividend streak (yrs) SEC XBRL | 5 | 5 | Tie |
| Beta as of 2026-07-23 | 0.48 | 0.74 | |
| 1-year return as of 2026-07-22 close | +15.7% | -50.9% | PAHC higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.